Ranogem ER 500 – Ranolazine Extended Release Tablets 500 mg – 1 × 10 Tablets

Ranogem ER 500 Tablets deliver a high-quality, clinically proven anti-anginal therapy meticulously designed for the long-term management of chronic stable angina pectoris. By utilizing a specialized Extended-Release (ER) matrix, this formulation ensures a steady, prolonged liberation of Ranolazine into the systemic circulation, preventing erratic peak-and-trough concentrations and offering sustained cardiac tissue protection throughout the day and night.

Unlike traditional anti-anginal drugs that lower heart rate or drop blood pressure to ease cardiac strain, Ranolazine operates via a unique metabolic channel. It acts as a selective inhibitor of the late inward sodium current ($I_{\text{Na}}$) in cardiac muscle cells. During ischemic conditions, this late sodium current becomes abnormally prolonged, leading to an intracellular accumulation of sodium ions, which in turn drives an overload of intracellular calcium via the sodium-calcium exchanger. This calcium overload increases mechanical wall tension, compromises myocardial relaxation, and worsens localized ischemia. By blocking this pathway, Ranogem ER 500 minimizes ionic imbalances, relaxes ventricular walls, improves coronary microcirculation, and preserves vital oxygen delivery parameters during physical exertion.

Key Benefits

• Targeted Anti-Anginal Protection: Significantly reduces the frequency of chronic chest pain episodes and minor ischemic events.

• Hemodynamically Neutral: Controls angina parameters without causing dangerous drops in baseline blood pressure or affecting heart rate metrics.

• Sustained 24-Hour Delivery: Extended-release matrix keeps active drug distributions uniform to prevent early morning ischemic vulnerabilities.

• Enhanced Physical Capacity: Enhances baseline exercise tolerance, allowing individuals to carry out daily physical tasks with less discomfort.

• Trusted Quality: Manufactured under the absolute pharmaceutical benchmarks of Steris Healthcare, ensuring accurate active ingredient release and uniformity.

Directions for Use

• Take exactly as directed by your cardiologist or primary physician.

• Swallow the tablet whole with a full glass of water. Do not crush, chew, break, or divide the tablet, as destroying the outer core will ruin the extended-release framework and release the full 500 mg strength too rapidly.

• Ranogem ER 500 can be taken with or without food. Maintain strict routine uniformity by consuming your dose at the exact same times every single day.

Safety & Precautions

• Do not stop taking this medication suddenly. Halting anti-anginal maintenance protocols abruptly can cause a rapid, severe return of stable chest pain or acute cardiovascular stress.

• This medicine is intended for the long-term maintenance of chronic stable angina; it is not designed to treat acute, sudden angina attacks. For immediate chest pain crises, use your prescribed fast-acting sublingual nitroglycerin spray or tablet.

• Contraindicated for individuals with severe hepatic impairment (liver cirrhosis) or those concurrently taking strong CYP3A4 inhibitors (like certain antifungals or clarithromycin), as these compounds can elevate ranolazine systemic concentrations dangerously.

• Inform your specialist if you have a history of kidney disorders or a documented personal or family history of QT interval prolongation before initializing treatment.

• Keep out of reach of children.

Storage

• Store in a cool, dry place below 30°C.

• Protect from direct sunlight, excessive heat, and environmental room moisture.

• Keep the tablets safely stored inside their original blister configuration until the exact time of consumption.